Search

Your search keyword '"Gholizadeh Navashenaq, J"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Gholizadeh Navashenaq, J" Remove constraint Author: "Gholizadeh Navashenaq, J"
41 results on '"Gholizadeh Navashenaq, J"'

Search Results

1. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

2. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

3. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

4. The global burden of cancer attributable to risk factors, 2010–19 : A systematic analysis for the Global Burden of Disease Study 2019

5. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

6. Recent advances with erythrocytes as therapeutics carriers.

7. Protective effects of 17-β-estradiol on liver injury: The role of TLR4 signaling pathway and inflammatory response.

8. Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders.

9. Nanoparticles-based therapeutics for the management of bacterial infections: A special emphasis on FDA approved products and clinical trials.

10. From traditional medicine to modern oncology: Scutellarin, a promising natural compound in cancer treatment.

11. The prognostic and therapeutic potential of HO-1 in leukemia and MDS.

12. The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia.

13. CRISPR/Cas9, a promising approach for the treatment of β-thalassemia: a systematic review.

14. The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies.

15. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.

16. microRNAs: Small molecules with a large impact on colorectal cancer.

17. A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation.

18. The molecular biology and therapeutic potential of Nrf2 in leukemia.

19. The role of Pycnogenol in the control of inflammation and oxidative stress in chronic diseases: Molecular aspects.

20. NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases.

21. The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?

22. Does CCL19 act as a double-edged sword in cancer development?

23. The effect of HTLV1 infection on inflammatory and oxidative parameters in the liver, kidney, and pancreases of BALB/c mice.

24. Does propolis have any effect on rheumatoid arthritis? A review study.

25. Effects of Melatonin and Propolis Supplementation on Inflammation, Oxidative Stress, and Clinical Outcomes in Patients with Primary Pneumosepsis: A Randomized Controlled Clinical Trial.

26. A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections.

27. Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.

28. PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity.

29. HTLV-1 oncovirus-host interactions: From entry to the manifestation of associated diseases.

30. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.

31. The effect of French maritime pine bark extract supplementation on inflammation, nutritional and clinical status in critically ill patients with traumatic brain injury: A randomized controlled trial.

32. Curcumin and cancer; are long non-coding RNAs missing link?

33. Chemokine CXCL14; a double-edged sword in cancer development.

34. Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches.

35. Effect of propolis supplementation on athletic performance, body composition, inflammation, and oxidative stress following intense exercise: A triple-blind randomized clinical trial.

36. CXC chemokine ligand 16: a Swiss army knife chemokine in cancer.

37. Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility.

38. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.

39. Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial.

40. Effects of propolis and melatonin on oxidative stress, inflammation, and clinical status in patients with primary sepsis: Study protocol and review on previous studies.

41. Study of curcumin immunomodulatory effects on reactive astrocyte cell function.

Catalog

Books, media, physical & digital resources